Northside Capital Management, LLC Amgen Inc Transaction History

Northside Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 22, 2021	SELL	$216.38 - $257.67 $621,226 - $739,770	-2,871 Closed	0 $0
Q3 2019 Oct 11, 2019	SELL	$174.11 - $208.62 $13,058 - $15,646	-75 Reduced 2.55%	2,871 $556,000
Q4 2018 Jan 14, 2019	BUY	$178.4 - $208.25 $13,380 - $15,618	75 Added 2.61%	2,946 $573,000
Q3 2017 Oct 20, 2017	BUY	$167.29 - $191.0 $480,289 - $548,361	2,871	2,871 $535,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Northside Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Northside Capital Management, LLC with notifications on news.